Inflammatory bowel disease: between genetics and microbiota N Younis, R Zarif, R Mahfouz Molecular biology reports 47, 3053-3063, 2020 | 94 | 2020 |
Hydroxychloroquine in COVID-19 patients: pros and cons NK Younis, RO Zareef, SN Al Hassan, F Bitar, AH Eid, M Arabi Frontiers in Pharmacology 11, 597985, 2020 | 38 | 2020 |
Cardiac manifestations in COVID-19 patients: a focus on the pediatric population T Abi Nassif, G Fakhri, NK Younis, R Zareef, F Al Amin, F Bitar, M Arabi Canadian Journal of Infectious Diseases and Medical Microbiology 2021, 2021 | 30 | 2021 |
COVID-19 in pediatric patients: a focus on CHD patients RO Zareef, NK Younis, F Bitar, AH Eid, M Arabi Frontiers in Cardiovascular Medicine 7, 612460, 2020 | 29 | 2020 |
COVID-19: potential therapeutics for pediatric patients NK Younis, RO Zareef, G Fakhri, F Bitar, AH Eid, M Arabi Pharmacological Reports 73, 1520-1538, 2021 | 21 | 2021 |
Aspirin in COVID-19: Pros and cons R Zareef, M Diab, T Al Saleh, A Makarem, NK Younis, F Bitar, M Arabi Frontiers in Pharmacology 13, 849628, 2022 | 16 | 2022 |
Inflammatory bowel disease: A key role for microbiota? R Zareef, N Younis, R Mahfouz Meta Gene 25, 100713, 2020 | 14 | 2020 |
The era of the coronavirus disease 2019 pandemic: a review on dynamics, clinical symptoms and complications, diagnosis, and treatment NK Younis, RO Zareef, MAN Maktabi, R Mahfouz Genetic Testing and Molecular Biomarkers 25 (2), 85-101, 2021 | 11 | 2021 |
Tamponade and massive pleural effusions secondary to peripherally inserted central catheter in neonates–A complication to be aware of R Zareef, M Anka, T Hatab, I El Rassi, K Yunis, F Bitar, M Arabi Frontiers in Cardiovascular Medicine 10, 1092814, 2023 | 4 | 2023 |
Myocarditis in COVID-19: a focus on the pediatric population B Sleem, R Zareef, F Bitar, M Arabi American Journal of Cardiovascular Disease 13 (3), 138, 2023 | 4 | 2023 |
Low molecular weight heparin in COVID-19: benefits and concerns A Makarem, R Zareef, J Abourjeili, JE Nassar, F Bitar, M Arabi Frontiers in Pharmacology 14, 1159363, 2023 | 3 | 2023 |
Corticosteroids in COVID-19: pros and cons A Bahsoun, Y Fakih, R Zareef, F Bitar, M Arabi Frontiers in Medicine 10, 2023 | 3 | 2023 |
The emerging role of the gut microbiome in the cancer response to immune checkpoint inhibitors: A narrative review G Araji, J Maamari, FA Ahmad, R Zareef, P Chaftari, SCJ Yeung Journal of Immunotherapy and Precision Oncology 5 (1), 13-25, 2022 | 3 | 2022 |
Dispensing and Purchasing Antibiotics Without Prescription: A Cross-sectional Study Among Pharmacists and Patients in Beirut, Lebanon R Kakati, S Nakad Borrego, R Zareef, J Atallah, S Farhat, N Daye, ... INQUIRY: The Journal of Health Care Organization, Provision, and Financing …, 2023 | 2 | 2023 |
COVID-19 in congenital heart disease patients: what did we learn?! R Zareef, E Salameh, R Hammoud, T Tannouri, F Bitar, M Arabi Frontiers in Cardiovascular Medicine 10, 2023 | 2 | 2023 |
Pulmonary artery debanding in the cath lab: Lessons learned! R Zareef, SA Hassan, N Younis, T Tannoury, IE Rassi, F Bitar, M Arabi Frontiers in Cardiovascular Medicine 9, 950123, 2022 | 2 | 2022 |
Neglected Tropical Diseases in Lebanon W Alam, T Mobayed, N Younis, R Zarif, N Bizri, H Tamim, U Musharrafieh, ... Acta Parasitologica 67 (2), 809-819, 2022 | 2 | 2022 |
Pathogenesis and distribution of infective endocarditis in the pediatric population: a 20-year experience in a tertiary care center in a developing country M Rashed, G Fakhri, R Zareef, N Abdul Halim, M Ahmed, G Dbaibo, ... Frontiers in Cardiovascular Medicine 10, 1182468, 2023 | 1 | 2023 |
Pre-operative assessment of pediatric congenital heart disease patients in the COVID-19 era: lessons learned NK Younis, RO Zareef, MA Diab, O El Sedawi, IM El-Rassi, F Bitar, ... Cardiology in the Young 32 (4), 618-622, 2022 | 1 | 2022 |
Pulmonary artery banding: a 20-year experience at a tertiary care center in a developing country R Ghoussaini, R Zareef, A Makarem, N Younis, S Al Hassan, I El Rassi, ... Frontiers in Cardiovascular Medicine 11, 1368921, 2024 | | 2024 |